GranuFlo Cardiac Events May Be More Likely To Occur With GranuFlo Dry Acid Products

GranuFlo is a product that is manufactured by Fresenius Medical Care Labs.  It is used during dialysis as part of the dialysate mixture.  Dialysate combines ultra-pure water, bicarbonate concentrate, and acid concentrate to aid in removing toxic waste from the blood system by neutralizing the acids that build up in the blood.

A memo from Fresenius Medical Care Lab noted, that people being prescribed GranuFlo during their dialysis treatments were suffering increased instances of cardiac arrest.  But, it does not appear that Fresenius Medical Care Lab shared this information with the FDA (Food and Drug Administration) or with patients being administered GranuFlo.  In fact, as many as 941 patients have suffered cardiac arrest due to improper administration of the GranuFlo dry acid product.

Are there any GranuFlo Lawsuits Currently?

Yes, the first GranuFlo lawsuit was filed on October 1st 2012.  The suit alleges that the death of the plaintiffs family member was a direct result of the administration of GranuFlo and that the makers of GranuFlo knew that there was an increased risk of heart attacks with GranuFlo as early as November 2011.

Has GranuFlo Been Recalled?

Yes, after the FDA became aware of the link between heart attacks and Granuflo, GranuFlo was issued  a class 1 recall (the most significant recall the FDA issues) in March of 2012.

You have the right to trust your medication is safe.  Tragically, this is not always the case.  Well versed in the product liability laws that protect consumers, our GranuFlo attorneys have handled countless lawsuits involving harmful pharmaceuticals.  If you or a loved one have experienced side effects as a result of GranuFlo, contact our GranuFlo lawyers today.